LINDA BIXLER: Open Payments
NPI 1053715573 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 35 payments from 12 companies in 2025. Trend: 2023 $673 · 2024 $807 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $240 |
| Corcept Therapeutics | 4 | $175 |
| Amgen Inc. | 4 | $70 |
| Novo Nordisk Inc | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| ABBVIE INC. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: ELIQUIS, Korlym, OTEZLA, NURTEC ODT, Ozempic, INSPIRE, Auvelity, SHINGRIX.
Industry payments across GA — which companies pay providers there.
